Mycophenolate mofetil in the treatment of systemic lupus erythematosus: comment on the article by Hervier et al Reply

被引：0
|
作者：
Hervier, Baptiste [1 ,2 ]
Vieillard, Vincent [2 ,3 ]
机构：
[1] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, Paris, France
[2] INSERM UMR S 945, Paris, France
[3] Univ Paris 06, Paris, France
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
NATURAL-KILLER-CELLS; DISEASE-ACTIVITY; KILLING DEFECT; INTERFERON;
D O I：
10.1002/art.34586
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3489 / 3490
页数：2
相关论文
共 50 条
  • [41] Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
    FF Falcini
    CS Capannini
    MG Martini
    LTF La Torre
    VA Vitale
    NF Nacci
    MCM Matucci Cerinic
    CR Cimaz
    ZF Zulian
    Pediatric Rheumatology, 6 (Suppl 1)
  • [42] Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement
    Hanjani, NM
    Nousari, CH
    ARCHIVES OF DERMATOLOGY, 2002, 138 (12) : 1616 - 1618
  • [43] Mycophenolate Mofetil (MMF) Treatment in Paediatric Onset Systemic Lupus Erythematosus
    Kazyra, I.
    Pilkington, C.
    Marks, S. D.
    Tullus, K.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1807 - 1807
  • [44] Is mycophenolate mofetil a safe and effective treatment for patients with systemic lupus erythematosus?
    Daniel J Wallace
    Nature Clinical Practice Rheumatology, 2006, 2 (1): : 16 - 17
  • [45] Epidemiology of systemic lupus erythematosus in the United Kingdom: Comment on the article by Somers et al
    de Vries, Corinne
    Nightingale, Alison
    Farmer, Richard
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (02): : 297 - 297
  • [46] APRIL in systemic lupus erythematosus: Essential or dispensable? Comment on the article by Jacob et al
    Pan, Hai-Feng
    Wang, De-Guang
    Ye, Dong-Qing
    ARTHRITIS AND RHEUMATISM, 2012, 64 (06): : 2052 - 2053
  • [47] Estimates of the US prevalence of systemic lupus erythematosus: comment on the article by Lawrence et al
    Wilson, WA
    ARTHRITIS AND RHEUMATISM, 1999, 42 (02): : 396 - 396
  • [48] Characterization of flares in patients with systemic lupus erythematosus: comment on the article by Ho et al
    Ayoub, N
    Ayoub, G
    Rouphael, N
    ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 581 - 582
  • [49] Tolerability of mycophenolate mofetil in patients with systemic lupus erythematosus
    Riskalla, MM
    Somers, EC
    Fatica, RA
    McCune, WJ
    JOURNAL OF RHEUMATOLOGY, 2003, 30 (07) : 1508 - 1512
  • [50] Statement on the use of mycophenolate mofetil for systemic lupus erythematosus
    Aringer, M.
    Fischer-Betz, R.
    Hiepe, F.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 (06): : 575 - 580
12345